Blockade of Tumor Necrosis Factor-Alpha: A Role for Adalimumab in Neovascular Age-Related Macular Degeneration Refractory to Anti-Angiogenesis Therapy

Publisher： Karger

E-ISSN： 1663-2699|7|1|154-162

ISSN： 1663-2699

Source： Case Reports in Ophthalmology, Vol.7, Iss.1, 2016-03, pp. : 154-162

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Triple Therapy for Anti-Vascular Endothelial Growth Factor Nonresponders in Neovascular Age-Related Macular Degeneration: Impact of Different Photodynamic Therapy Parameters

By  

Ophthalmologica, Vol. 230, Iss. 3, 2013-08 ,pp. : 131-137

Karger

Access to resources Recommend Favorite

Neovascular Age-Related Macular Degeneration

By  

Ophthalmologica, Vol. 227, Iss. 1, 2012-04 ,pp. : 11-20

Karger

Access to resources Recommend Favorite

Influence of Vitreomacular Adhesion on Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration

By  

Ophthalmic Research, Vol. 58, Iss. 1, 2017-03 ,pp. : 18-26

Karger

Access to resources Recommend Favorite

Bimonthly Ranibizumab for Neovascular Age-Related Macular Degeneration

By  

Ophthalmologica, Vol. 231, Iss. 2, 2013-12 ,pp. : 80-85

Karger

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor Gene Polymorphisms and Risk of Neovascular Age-Related Macular Degeneration in a Chinese Cohort

By  

Ophthalmic Research, Vol. 45, Iss. 3, 2010-09 ,pp. : 142-148

Karger

Access to resources Recommend Favorite